Several Committees oversee EORTC’s strategy and independence as well as the relevance and scientific value of all research efforts, ensuring scientific work meets highest quality standards. Each EORTC Committee Chair is selected to serve a three-year term which may be renewed upon recommendation by the EORTC Board.
The Audit and Financial Committee (AC/FC)
The Audit and Financial Committee’s responsibilities include assisting the Board of the EORTC and the EORTC Cancer Research Fund, respectively, in their financial management. The AC/FC is an advisory voice for the Organisation’s long-term financial management principles and budgeting and financial reporting processes. The Committee ensures strong recommendations to the Board on financial matters.
The AC/FC hires, dismisses, and supervises auditors.
The Nominating Committee (NC)
The Nominating Committee acts as an advisory Committee to the Board regarding appointments of the President of the Board, the CEO, and the CFO. It also safeguards that the Organisation has formal, rigorous, and transparent procedures to support these decisions. The NC is chaired by the President in charge and is composed of the three Past Presidents.
The Executive Committee (ExCo)
The Executive Committee may be conducted upon need to expedite critical decisions. It expedites matters which require actions in between plenary Board meetings. It is not predefined, and participants are selected among the Board Members depending on the nature of the issues to be discussed.
The Scientific Audit Committee (SAC)
The Scientific Audit Committee gives independent advice to the EORTC Board and to the Scientific Chairs Council on the activities, scientific output, overall priorities and strategies of the EORTC. The SAC evaluates the effectiveness of research programmes and makes suggestions to strengthen the EORTC’s overall functioning. The SAC also serves as an advisory body to the EORTC Board to appoint Group leadership. The Committee’s Members represent a cross-section of international opinion leaders and experts, half of whom have no other EORTC involvement.